Sunday’s weekly recap looks back on the last seven days as an editor. This is done at the suggestion of his cartoonist Albert Jan Rasker. He chooses a subject, paints a picture and takes it from there. What were they talking about in the newsroom? What other topics have been highlighted? How does Innovation Origins really work? All can come. If you’d like this newsletter sent straight to your inbox every Sunday morning, subscribe here.
Albert Jan’s great selection this week is mainly because it allows us to discuss the difference between technology as gadgets and technology with missions. First, the article itself. It’s about Enliven, a startup that uses virtual reality to combat discrimination, inequality, and harassment. An excellent goal and, unfortunately, highly socially desirable.
Enliven is in the news with backing from Oost NL and LUMO Labs. A €1 million investment will allow Enliven to finalize the concept and seek out a customer base. This isn’t the first time LUMO Labs has invested in a “mission-driven” startup, just the beauty of an incubator like this. sustainable development goals. It’s also in their mission statement.We create impactful venture opportunities in emerging technologies”
And it’s very much in line with the Innovation Origins selection. Yes, technology is very important in innovation articles. But technology must always solve important things for society. As such, we find very little information about the latest iPhones, even less about developments related to healthcare, the energy transition, or the mobility dilemma. We are always looking for busy people and organizations to solve today’s and tomorrow’s challenges. In other words, make a real impact. It seemed like every day last week. Here’s a small selection:
something else that surprised us
Click here if you want to read it all. But the most impressive works are:
For the first time, injection of radioactive pellets for irradiation of liver tumors has been visualized live. An MRI scanner can be used to see if the radiation pellets are being delivered to the correct location in the patient’s tumor. This technology makes it possible to tailor the injection site and dose for each patient. Researchers at his Radboudumc in Nijmegen discovered this and applied it to liver cancer patients. The procedure is safe and feasible.
Thousands of pounds of fishing nets end up in the water each year. Marcel Alberts, founder of his Healix based in Maastricht, intends to make the oceans netless. He hopes to work with other companies to save marine life by hoisting nets out of the water and remaking raw polymers. Healix was our startup of the day.
Cheese is as old as mankind. It is a source of protein, calcium and vitamins. However, dairy production involves large greenhouse gas emissions and large water usage. As such, alternatives are eagerly sought. Researchers at the University of Copenhagen have discovered a way to make cheese from the plant protein of yellow peas.
Biochemist Christian Gruber at the Medical University of Vienna is investigating therapeutic applications based on plant and animal mechanisms. He is currently working on the question of how hormones from locusts could be used to treat humans.From insects to medicine.
Comments
Post a Comment